Primus In News
Shipping bottlenecks squeeze pharma flows as Hormuz crisis impact deepens
14-04-2026
Nilaya Varma, Co-Founder and Group CEO, Primus Partners, shares his view on how geopolitical tensions are driving up input costs in India’s pharma sector due to heavy reliance on Chinese APIs and vaccine raw materials, delaying shipments and straining exports to Gulf and emerging markets
Explore Related Insights
- India in the Semicon Party - All that and a bag of chips! Not yet
- Can strategic acquisitions give India’s semiconductor entrants an ecosystem?
- The Rise and fall of Prompt Engineering: A short-lived revolution
- Beyond the boundary: How AI is reshaping the IPL 2026 experience from the dugout to the stands
